From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization
AbstractAlloimmunization is an undesirable iatrogenic effect of transfusion and transplantation. In fact, recipients can be considered as responders or not responders, in a continuum from tolerance, including organ transplantation and transfusion, to polyimmunized and refractory patients. New models and large studies have enabled a better understanding of the mechanisms that induce specific alloantibody (alloAb) generation. Here, we focus on risk factors of alloimmunization. We review the alloantibody characteristics, summarize the different leukocytes involved in their induction, and suggest some hypotheses. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Prigent, A.; Maillard, N.; Absi, L.; Aloui, C.; Cognasse, F.; Laradi, S.; Mariat, C.; Garraud, O. From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization. Antibodies 2014, 3, 130-152.
Prigent A, Maillard N, Absi L, Aloui C, Cognasse F, Laradi S, Mariat C, Garraud O. From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization. Antibodies. 2014; 3(1):130-152.Chicago/Turabian Style
Prigent, Antoine; Maillard, Nicolas; Absi, Léna; Aloui, Chaker; Cognasse, Fabrice; Laradi, Sandrine; Mariat, Christophe; Garraud, Olivier. 2014. "From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization." Antibodies 3, no. 1: 130-152.